Literature DB >> 28560815

Covariate-adjusted borrowing of historical control data in randomized clinical trials.

Baoguang Han1, Jia Zhan2, Z John Zhong1, Dawei Liu1, Stacy Lindborg1.   

Abstract

The borrowing of historical control data can be an efficient way to improve the treatment effect estimate of the current control group in a randomized clinical trial. When the historical and current control data are consistent, the borrowing of historical data can increase power and reduce Type I error rate. However, when these 2 sources of data are inconsistent, it may result in a combination of biased estimates, reduced power, and inflation of Type I error rate. In some situations, inconsistency between historical and current control data may be caused by a systematic variation in the measured baseline prognostic factors, which can be appropriately addressed through statistical modeling. In this paper, we propose a Bayesian hierarchical model that can incorporate patient-level baseline covariates to enhance the appropriateness of the exchangeability assumption between current and historical control data. The performance of the proposed method is shown through simulation studies, and its application to a clinical trial design for amyotrophic lateral sclerosis is described. The proposed method is developed for scenarios involving multiple imbalanced prognostic factors and thus has meaningful implications for clinical trials evaluating new treatments for heterogeneous diseases such as amyotrophic lateral sclerosis.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ALS; Bayesian methods; covariate; hierarchical model; historical control

Mesh:

Year:  2017        PMID: 28560815     DOI: 10.1002/pst.1815

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  5 in total

1.  A group-sequential randomized trial design utilizing supplemental trial data.

Authors:  Ales Kotalik; David M Vock; Brian P Hobbs; Joseph S Koopmeiners
Journal:  Stat Med       Date:  2021-11-09       Impact factor: 2.373

2.  Dynamic borrowing in the presence of treatment effect heterogeneity.

Authors:  Ales Kotalik; David M Vock; Eric C Donny; Dorothy K Hatsukami; Joseph S Koopmeiners
Journal:  Biostatistics       Date:  2021-10-13       Impact factor: 5.899

3.  Suitability of external controls for drug evaluation in Duchenne muscular dystrophy.

Authors:  Nathalie Goemans; James Signorovitch; Gautam Sajeev; Zhiwen Yao; Heather Gordish-Dressman; Craig M McDonald; Krista Vandenborne; Debra Miller; Susan J Ward; Eugenio Mercuri
Journal:  Neurology       Date:  2020-07-01       Impact factor: 9.910

4.  Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials.

Authors:  John D Seeger; Kourtney J Davis; Michelle R Iannacone; Wei Zhou; Nancy Dreyer; Almut G Winterstein; Nancy Santanello; Barry Gertz; Jesse A Berlin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-04       Impact factor: 2.890

5.  Summarising salient information on historical controls: A structured assessment of validity and comparability across studies.

Authors:  Anthony Hatswell; Nick Freemantle; Gianluca Baio; Emmanuel Lesaffre; Joost van Rosmalen
Journal:  Clin Trials       Date:  2020-09-21       Impact factor: 2.486

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.